first international export order for travelan

First International Export Order for Travelan
Australian developed therapeutic product begins global expansion

Australian biopharmaceutical company Anadis Limited (ASX:ANX) is pleased to announce the Canadian distributor, Valeo Pharma, have placed their initial order for Travelan - used to reduce the risk of Travellers' Diarrhoea. This is a significant order for 10,000 packets, representing the first wholesale order for Travelan to an established overseas distributor of healthcare products. Canada is seen as a crucial market in expanding Travelan into North America.

Valeo Pharma is investing significant resources in the areas of marketing and product promotions in order to establish Travelan with in Canada. The distribution agreement sees Valeo Pharma as the Canadian distributor for at least the next 5 years, commencing with this initial order.

Anadis anticipates the international distribution of Travelan to grow, with the expectation of the appointment of a US distributor in the short term, and subsequent order, as well as entry into additional international markets.

The Canadian Market
The product launch will coincide with the "Snow Bird" travel season, as many Canadians travel to warmer climates to escape the winter. Popular destinations include the high travellers' diarrhoea risk destinations of Mexico, The Caribbean and Latin America.

The Canadian market is seen as a stepping stone to the US market, but is important nevertheless being approximately 30% larger than Australia (with a population of approximately 30 million).

[continues]

Pezz